WASHINGTON, April 25, 2023 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) today announced results for the first quarter 2023. Net earnings refer to net earnings attributable to common shareholders. For the quarter ended March 31, 2023 net earnings were $1.4 billion, or $1.94 per diluted common share and non-GAAP adjusted diluted net earnings per... Read more
Danaher Announces Conversion Date for Series B Mandatory Convertible Preferred Stock WASHINGTON, April 10, 2023 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced today that its 5.00% Series B Mandatory Convertible Preferred Stock (the “Preferred Stock”), will automatically convert into shares of the Company’s common stock on April 17, 2023 (the “Conversion Date”). The conversion rate... Read more
WASHINGTON, March 27, 2023 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the first quarter 2023 on Tuesday, April 25, 2023 beginning at 8:00 a.m. ET and lasting approximately 1 hour. During the call, the company will discuss its financial performance, as well as future expectations.... Read more
Danaher Partners with the University of Pennsylvania’s Center for Cellular Immunotherapies to Address Manufacturing Challenges Impacting the Uptake of Cell Therapies WASHINGTON, March 7, 2023 /PRNewswire/ — Danaher Corporation (NYSE: DHR), a global science and technology innovator, today announced a strategic partnership with the University of Pennsylvania (Penn) focusing on cell therapy innovation. The multi-year... Read more
Danaher Announces New Environmental and Applied Solutions Company to Be Named Veralto WASHINGTON, Feb. 8, 2023 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (“Danaher”) today announced that Veralto Corporation (“Veralto” or the “Company”) will be the name of the separate public company Danaher intends to create in the fourth quarter of 2023. Veralto will be comprised... Read more
WASHINGTON, Jan. 24, 2023 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) today announced results for the fourth quarter and full year 2022. All results in this release reflect only continuing operations unless otherwise noted. Net earnings refers to net earnings attributable to common shareholders. For the quarter ended December 31, 2022, net earnings were... Read more
WASHINGTON, Dec. 27, 2022 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the fourth quarter 2022 on Tuesday, January 24, 2023 beginning at 8:00 a.m. ET and lasting approximately 1 hour. During the call, the company will discuss its financial performance, as well as future expectations.... Read more
Danaher Launches Beacon Initiative and Its First Partnership Focused on Gene Therapy Innovation WASHINGTON, Nov. 10, 2022 /PRNewswire/ — Danaher Corporation (NYSE: DHR), a global science and technology innovator, today announced that it has entered a strategic partnership with Duke University to form its first Danaher Beacon for Gene Therapy Innovation. Danaher Beacons is a... Read more
WASHINGTON, Oct. 20, 2022 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) today announced results for the third quarter 2022. All results in this release reflect only continuing operations unless otherwise noted. For the quarter ended September 30, 2022, net earnings were $1.6 billion, or $2.10 per diluted common share which represents a 36.0% year-over-year... Read more
Danaher Releases 2022 Sustainability Report and Announces New Greenhouse Gas Emissions Reduction Target WASHINGTON, Oct. 5, 2022 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”), the global science and technology innovator, today published its 2022 Sustainability Report which highlights the progress of the Company’s sustainability program. Danaher also announced it has set a new goal to... Read more